Jurors are still deliberating over the fate of Elizabeth Holmes, the founder of defunct biotech company Theranos. They’re deciding if she intentionally misled investors, patients, and doctors about what her company’s blood testing technology could do. Because despite big promises, the tech the company claimed to have invented… didn’t actually exist.
And the technology might never be a reality — at least not in the way Holmes described it. In this episode of our three-part series on Theranos, we look at what researchers actually think is possible in the field of blood testing and what the future could look like.